ICP-MS

Determination of element traces; determination of osmium

Therapeutic Modalities:

Biologics, Cell & Gene Therapies, Small Molecules

Development Phases:

Research, Preclinical, Early-phase Clinical, Late-Phase Clinical, Commercial

Quality Standard:

GMP and non-GMP (ISO 9001:2015)

Pharmacopoeia:

Ph. Eur. 01/2008:20258, USP/NF <730>, USP/NF <233>; Ph. Eur. 2.2.58 and 2.4.20, USP<730> and <233>, JP<2.63> and <2.66>